Physician profile
Timothy Gostkowski
NPI 1992784268
$7,235.50
in general payments reported to CMS, 2019-2025
17 companies · $1,443 in 2025
The $1,443 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $250 · 2021: $479 · 2022: $180 · 2023: $324 · 2024: $4,206 · 2025: $1,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,024 · Food and Beverage: $1,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,024.45 |
| Food and Beverage | $1,448.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,066.07 | 2024-2025 | |
| Abbott Laboratories | $2,405.11 | 2019-2025 | Aveir, Jot Dx, Assurity |
| Kci USA, INC. | $143.38 | 2021 | |
| Merck Sharp & Dohme LLC | $85.72 | 2021-2024 | Bridion |
| Innocoll Pharmaceuticals Limited | $77.76 | 2021-2022 | |
| Integra Lifesciences Corporation | $69.49 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Solventum Corporation | $52.55 | 2024-2025 | Activ.A.C. |
| Medtronic, INC. | $49.89 | 2024-2025 | Progrip, Signia |
| Tela Bio, INC. | $46.01 | 2024 | Ovitex 2s |
| Olympus America INC. | $46.00 | 2024 | Olympus |
| Boston Scientific Corporation | $41.27 | 2023 | Spyglass |
| Teleflex LLC | $40.61 | 2021-2023 | Urolift |
| Becton, Dickinson and Company | $30.55 | 2025 | Arista |
| Takeda Pharmaceuticals U.S.A., INC. | $26.43 | 2022 | |
| Davol INC. | $22.95 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.43 | 2024 | |
| Biomerieux INC | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Gostkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.